We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

33 hedge funds and large institutions have $353M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$90.7M
2
RCM
RA Capital Management
Massachusetts
+$60.8M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$35.4M
4
APM
Avidity Partners Management
Texas
+$33.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MS
26
Maven Securities
Jersey
$217K +$204K +10,870 New
AA
27
AlphaCentric Advisors
Puerto Rico
$21K +$18.7K +1,000 New
PCM
28
Pinz Capital Management
New York
$21K +$18.7K +1,000 New
UBS Group
29
UBS Group
Switzerland
$10K +$8.43K +450 New
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$6K +$5.53K +295 New
ACM
31
ACT Capital Management
Pennsylvania
$2K +$1.69K +90 New
Morgan Stanley
32
Morgan Stanley
New York
$1K +$1.31K +70 New
Bank of America
33
Bank of America
North Carolina
– +$187 +10 New
1
2

CYT Hedge Fund Activity: Q2 2021 in Review

33 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q2 2021, worth a combined $353M.

Buyers outnumbered sellers: 33 funds opened new CYT positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $90.7M.

  • 33 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $353M of Cyteir Therapeutics, Inc. Common Stock stock for Q2 2021.
  • 33 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +33 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q2 2021 was Novo Holdings A/S, an estimated $90.7M added.

Based on aggregated 13F filings for Q2 2021.